The Journal of Pain
Volume 10, Issue 2 , Pages 201-207 , February 2009

Differential Roles of Peripheral Mitogen-Activated Protein Kinase Signal Transduction Pathways in Bee Venom–Induced Nociception and Inflammation in Conscious Rats

Received 1 March 2008 ,Revised 28 August 2008 ,Accepted 29 August 2008.

References 

  1. Cao FL, Liu MG, Hao J, Li Z, Lu ZM, Chen J. Different roles of spinal p38 and c-Jun N-terminal kinase pathways in bee venom-induced multiple pain-related behaviors. Neurosci Lett. 2007;427:50–54
  2. Chen HS, Chen J. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: Effect of systemic MK-801, a non-competitive NMDA receptor antagonist. Eur J Pain. 2000;4:389–401
  3. Chen J, Chen HS. Pivotal role of capsaicin-sensitive primary afferents in development of both heat and mechanical hyperalgesia induced by intraplantar bee venom injection. Pain. 2001;91:367–376
  4. Chen HS, He X, Wang Y, Wen WW, You HJ, Arendt-Nielsen L. Roles of capsaicin-sensitive primary afferents in differential rat models of inflammatory pain: A systematic comparative study in conscious rats. Exp Neurol. 2007;204:244–251
  5. Chen HS, Lei J, He X, Qu F, Wang Y, Wen WW, et al. Peripheral involvement of PKA and PKC in subcutaneous bee venom-induced persistent nociception, mechanical hyperalgesia, and inflammation in rats. Pain. 2008;135:31–36
  6. Chen HS, Lei J, He X, Wang Y, Wen WW, Wei XZ, et al. Pivotal involvement of neurogenic mechanism in subcutaneous bee venom induced inflammation and allodynia in unanesthetized conscious rats. Exp Neurol. 2006;200:386–391
  7. Ciruela A, Dixon AK, Bramwell S, Gonzalez MI, Pinnock RD, Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br J Pharmacol. 2003;138:751–756
  8. Crown ED, Ye Z, Johnson KM, Xu GY, McAdoo DJ, Hulsebosch CE. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp Neurol. 2006;199:397–407
  9. Cui XY, Dai Y, Wang SL, Yamanaka H, Kobayashi K, Obata K, et al. Differential activation of p38 and extracellular signal-regulated kinase in spinal cord in a model of bee venom-induced inflammation and hyperalgesia. Mol Pain. 2008;4:17
  10. Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H, et al. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci. 2002;22:7737–7745
  11. Huang JH, Zhang XM, McNaughton PA. Modulation of temperature-sensitive TRP channels. Semin Cell Dev Biology. 2006;17:638–645
  12. Ji RR. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy. 2004;3:299–303
  13. Ji RR. Mitogen-activated protein kinases as potential targets for pain killers. Curr Opin Investig Drugs. 2004;5:71–75
  14. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociception specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999;2:1114–1119
  15. Ji RR, Befort K, Brenner GJ, Woolf CJ. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci. 2002;22:478–485
  16. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002;36:57–68
  17. Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain. 2007;3:33
  18. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci. 2003;23:4017–4022
  19. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy: From molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754:253–262
  20. Kim SY, Bae JC, Kim JY, Lee HL, Lee KM, Kim DS, et al. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport. 2002;13:2483–2486
  21. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739–746
  22. Ma W, Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Exp Opin Ther Targets. 2005;9:699–713
  23. Marzo VD, Blumberg PM, Szallasi A. Endovanilloid signaling in pain. Curr Opin Neurobiol. 2002;12:372–379
  24. Nagy I, Santha P, Jancso G, Urban L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol. 2004;500:351–369
  25. Obata K, Noguchi K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci. 2004;74:2643–2653
  26. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci. 2004;24:10211–10222
  27. Sammons MJ, Raval P, Davey PT, Rogers D, Parsons AA, Bingham S. Carrageenan-induced thermal hyperalgesia in the mouse: role of nerve growth factor and the mitogen-activated protein kinase pathway. Brain Res. 2000;876:48–54
  28. Schäfers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. Neuroscience. 2003;23:2517–2521
  29. Schett G, Zwerina J, Firestein G. The p38 mitogen activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis. 2008;67:909–916
  30. Schindler JF, Monahan JB, Smith WG. p38 pathway kinases as anti-inflammatory drug targets. J Dent Res. 2007;86:800–811
  31. Seino D, Tokunaga A, Tachibana T, Yoshiya S, Dai Y, Obata K, et al. The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain. 2006;123:193–203
  32. Sweitzer SM, Peters MC, Ma JY, Kerr I, Mangadu R, Chakravarty S, et al. Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain. 2004;111:278–285
  33. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia. 2004;45:89–95
  34. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79:143–180
  35. Yu YQ, Chen J. Activation of spinal extracellular signaling-regulated kinases by intraplantar melittin injection. Neurosci Lett. 2005;381:194–198
  36. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005;114:149–159
  37. Zhuang ZY, Xu H, Clapham DE, Ji RR. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci. 2004;24:8300–8309
  38. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

 Supported by grants from the National Natural Science Foundation of the P.R. China (30471667) and the Postdoctoral Science Foundation of the P.R. China (2005037760) to Dr Hui-Sheng Chen.

PII: S1526-5900(08)00734-7

doi: 10.1016/j.jpain.2008.08.011

The Journal of Pain
Volume 10, Issue 2 , Pages 201-207 , February 2009

Article Tools

* Image Usage & Resolution